Keri Medical
Keri Medical is a Swiss medical device company that develops and commercializes implants, instruments, and AI-assisted 3D planning software exclusively for hand and wrist surgery, serving orthopaedic and plastic surgeons in more than 35 countries under the Medartis Group.
- Company typePrivate
- Founded2016
- HeadquartersGeneva, Switzerland
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Keri Medical does
Keri Medical SA, founded in 2016 in Plan-les-Ouates (Geneva, Switzerland) by Bernard Prandi and Dougal Bendjaballah, is a medical device company exclusively focused on implants and instruments for hand and wrist surgery. The company addresses a segment of orthopaedics that large multinationals have historically under-served, and operates across more than 35 countries through direct sales teams in Switzerland, France, and Germany, supplemented by an international distributor network. Since 2025, Keri Medical has been a wholly-owned subsidiary of Medartis Holding AG (SIX: MED).
The product portfolio centres on arthroplasty and osteosynthesis solutions. The flagship TOUCH® family is a dual-mobility trapeziometacarpal (CMC 1) prosthesis for thumb osteoarthritis, offered in standard, 100% titanium (for metal-sensitive patients), and PLUS variants. Complementary products include the KeriKnife™ single-use sterile surgical instruments for minimally invasive ultrasound-guided procedures, KeriFlex® silicone finger joint implants, MOTEC® total wrist arthroplasty, and the KeriFix®, KeriLock®, and KeriFuse® fixation devices. KeriScience® provides AI-assisted 3D preoperative planning, a K-Wire Guide, and a TMC clinical registry, while KeriAcademy delivers cadaver-lab and virtual-reality training to surgeons.
Keri Medical generates revenue through the direct sale of hardware (implants and single-use instruments) to healthcare institutions and surgeons, with pricing negotiated commercially rather than publicly disclosed. The go-to-market relies on field sales, congress presence (FESSH, GEM, ASSH, SOO), KeriAcademy training as a demand-generation engine, and regional distributors outside the company's direct-sales geographies. Key regulatory milestones in 2025-2026 include FDA Premarket Approval for TOUCH® CMC 1 in the US (September 2025), the 5B ODEP rating in the UK (May 2025), and listing on Australia's Prescribed List (effective July 2026).
Keri Medical firmographics
Firmographics- Name
- Keri Medical
- Legal name
- KERI MEDICAL SA
- Website
- https://kerimedical.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Keri Medical is a Swiss medical device company that develops and commercializes implants, instruments, and AI-assisted 3D planning software exclusively for hand and wrist surgery, serving orthopaedic and plastic surgeons in more than 35 countries under the Medartis Group.
- Ownership category
- akta.pro rank
Keri Medical industry classification
Industry- Product category
- Orthopedic Medical Devices (Hand and Wrist Surgery Implants)
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Hand & Upper Extremity (HLAKALAF)
- akta.pro secondary industries
- Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA), Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM), Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG)
Keywords
Where Keri Medical is headquartered
LocationHeadquarters
- HQ city
- Geneva
- HQ country
- Switzerland
- HQ region
- Europe
Offices3 records
Markets served
Keri Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Medical Device Sales: KeriMedical generates revenue through the sale of surgical implants and instruments exclusively dedicated to hand and wrist surgery. Products include prostheses (TOUCH® family, MOTEC®), surgical instruments (KeriKnife™), and fixation devices (KeriFix®, KeriLock®, KeriFuse®). Revenue flows through direct sales to healthcare institutions and distribution partnerships across 35+ countries.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
Keri Medical product offering
Product offeringCore offering
KeriMedical designs, manufactures, and commercializes medical devices exclusively dedicated to hand and wrist surgery, including arthroplasty prostheses (TOUCH® family of dual-mobility CMC 1 implants in standard, titanium, and PLUS variants, plus MOTEC® total wrist arthroplasty), surgical instruments (KeriKnife™ single-use ultrasound-guided knives), silicone finger joint implants (KeriFlex®), and fixation devices (KeriFix®, KeriLock®, KeriFuse®). The company supports these hardware products with the KeriScience® AI-powered 3D surgical planning platform and the KeriAcademy surgeon training program. Products are sold to healthcare institutions and surgeons in 35+ countries.
Product overview
KeriMedical is a specialized medical device company exclusively focused on hand and wrist surgery, founded in 2016 and now part of the Medartis Group. The product portfolio centers on arthroplasty and osteosynthesis devices, with the TOUCH® family (dual-mobility trapeziometacarpal prosthesis in standard, titanium, and PLUS variants) as the flagship offering. Supporting products include KeriKnife™ (single-use surgical instruments for minimally invasive procedures), KeriFlex® (silicone finger joint implants), KeriFix®, KeriFuse®, KeriLock®, and MOTEC® (total wrist arthroplasty). The digital ecosystem comprises KeriScience® (AI-powered 3D surgical planning platform) and KeriAcademy (surgeon training and education program). Operations span over 35 countries with key regulatory approvals including FDA PMA and Australia Prescribed List.
Differentiator
Problem solved
Functional benefit
Brands
- TOUCH®: Dual-mobility trapeziometacarpal prosthesis for thumb arthritis treatment, including TOUCH® Titanium (100% titanium version) and TOUCH® PLUS variants.
- KeriKnife™
- KeriFlex®
- MOTEC®
- KeriAcademy
- KeriScience®
Products and services
- TOUCH® Dual Mobility CMC 1 Prosthesis Dual-mobility trapeziometacarpal (CMC 1) prosthesis for treating degenerative thumb osteoarthritis (rhizarthrosis) while preserving the trapezium bone. Available in standard, titanium, hemispherical, and PLUS variants. Targets orthopedic and plastic hand surgeons treating thumb arthritis patients.
- TOUCH® Titanium (100% titanium CMC 1 prosthesis) 100% titanium version of the TOUCH® dual-mobility CMC 1 prosthesis, designed for patients with metal sensitivities or allergies. Identical dimensions and design to the standard TOUCH® for seamless surgical transition and inventory compatibility.
- TOUCH® PLUS New product extension of the TOUCH® CMC 1 prosthesis portfolio, available in Titanium and Standard variants. Targeted at younger or very active patients requiring CMC joint reconstruction.
- KeriKnife™ and KeriKnife™ Mini Single-use, sterile surgical knives designed for minimally invasive, ultrasound-guided procedures in hand surgery, including carpal tunnel release and trigger finger release. Reduces reprocessing costs and improves procedural safety. Targets hand surgeons performing minimally invasive soft tissue release.
- KeriFlex® (silicone finger joint implants) Silicone finger joint implants for PIP (Proximal Interphalangeal) and MCP (Metacarpophalangeal) joint replacement, restoring hand function and mobility in patients with finger joint arthritis. Targets hand surgeons performing finger joint reconstruction.
- MOTEC® (Total Wrist Arthroplasty System) Total wrist arthroplasty system for complete wrist joint replacement, part of the KeriAcademy training curriculum. Targets orthopedic and hand surgeons treating patients with wrist arthritis requiring total joint replacement.
- KeriFix® (hand surgery fixation device) Implant device for hand surgery procedures, used in fixation applications. Tracked through the KeriMedical product complaint and adverse event reporting system. Targets hand surgeons performing osteosynthesis procedures.
- KeriLock® (locking fixation device) Implant device for hand surgery procedures, included in KeriMedical product complaint and tracking system. Targets hand surgeons requiring locking fixation solutions for hand and wrist procedures.
- KeriFuse® (hand surgery fusion device) Implant device for hand surgery fusion applications, referenced in the KeriMedical complaint management system. Targets hand surgeons performing joint fusion procedures.
- KeriScience® (AI-powered 3D surgical planning platform) Digital surgical planning platform featuring AI-powered 3D planning, K-Wire Guide, and TMC Registry for TOUCH® prosthesis. Uses computer vision to convert CT imaging into 3D models for preoperative planning of CMC 1 prosthesis placement. Exclusively for healthcare professionals.
- KeriAcademy (surgical training program) Structured surgical training program offering hands-on cadaver workshops, virtual reality training, and technique demonstrations for hand and wrist surgery. Covers TOUCH®, KeriKnife™, and MOTEC® procedures. Limited to 10 participants per session with expert faculty of recognized surgeons.
Quantifiable outcome
- ODEP 5B rating confirms at least 5 years of published clinical data with acceptable evidence of long-term performance
- +1 more outcomes
Companies that use Keri Medical
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles2 records
Keri Medical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature8 records
Keri Medical partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered supporting, core and minor.
- One Ortho / SynAApSsupportingKeriScience platform data is hosted by SynAApS (Villeurbanne, France), managed by One Ortho. Data processing agreement under GDPR ensures compliance for healthcare data.
- EasyMedStat / OVH SASsupportingHealth data warehouse service hosted by OVH SAS (Roubaix, France), managed by EasyMedStat. Ensures secure storage of medical data per regulatory requirements.
- IRCAD StrasbourgcoreKeriMedical participates in IRCAD Strasbourg's 'Full Immersion in Arthroscopic & Ultrasound Surgery' course for hand surgery training. IRCAD is a leading international institute for minimally invasive surgery education.
- Oyonnax RugbyminorSponsorship partnership raising awareness about thumb arthritis (rhizarthrose) through sports community engagement.
- Anatole Facon (Sailor)minorSponsorship of young sailor who set North Atlantic crossing record. Partnership highlights themes of resilience, innovation, and precision that align with KeriMedical's values.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Keri Medical competitors and assessment
Company assessmentBroad incumbents
- Medartis: Swiss orthopaedic company (SIX: MED) that is the parent of KeriMedical and a direct incumbent in upper-extremity and hand/wrist fixation and arthroplasty. Operates a similar implant-and-instrument model but across broader anatomical areas.
- Integra LifeSciences: Global medical device company with a dedicated extremity orthopaedics and hand surgery portfolio (including silicone finger joint implants historically). Comparable B2B orthopaedic implant model serving hand and wrist surgeons.
- Stryker: Global orthopaedic incumbent with upper-extremity and extremities portfolios (acquired Wright Medical). Operates across much broader orthopaedic categories but overlaps with KeriMedical in hand/wrist and small-joint procedures.
- Zimmer Biomet: Major orthopaedic multinational with extremities and trauma lines addressing hand and wrist surgeons. Comparable in regulatory depth and global distribution but with a much broader portfolio.
- Johnson & Johnson MedTech (DePuy Synthes): Orthopaedic giant with hand and upper-extremity offerings through DePuy Synthes and previously Synthes. Overlaps with KeriMedical in trauma fixation of the hand/wrist and adjacent extremities.
- Smith+Nephew: Global medical device company with extremities, sports medicine, and trauma portfolios that include hand and wrist solutions. Comparable broad-orthopaedic peer with adjacent product overlap.
Direct peers
- Acumed: Specialist in upper-extremity and hand/wrist surgical solutions, including plating, fixation, and arthroplasty systems. Closely matches KeriMedical's surgical implant and instrumentation offering for hand and wrist surgeons.
- Skeletal Dynamics: Orthopaedic device company focused on upper extremity, including hand and wrist fracture fixation and arthroplasty. Similar specialist focus and surgeon-customer base to KeriMedical.
- TriMed: Developer of plates, screws, and implants for hand, wrist, and upper-extremity surgery. Direct specialist peer in implants and instruments for the same hand/wrist surgical community.
- Extremity Medical: Specialist in hand, wrist, and foot/ankle implants and fixation devices, including arthroplasty. Closely comparable niche orthopaedic player targeting the same hand/wrist surgeon community.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Keri Medical social profiles
Digital presenceKeri Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Keri Medical leadership team
Management profileNumber of profiles
Profiles2 records
Keri Medical funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Keri Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Keri Medical
What does Keri Medical do?
KeriMedical designs, manufactures, and commercializes medical devices exclusively dedicated to hand and wrist surgery, including arthroplasty prostheses (TOUCH® family of dual-mobility CMC 1 implants in standard, titanium, and PLUS variants, plus MOTEC® total wrist arthroplasty), surgical instruments (KeriKnife™ single-use ultrasound-guided knives), silicone finger joint implants (KeriFlex®), and fixation devices (KeriFix®, KeriLock®, KeriFuse®). The company supports these hardware products with the KeriScience® AI-powered 3D surgical planning platform and the KeriAcademy surgeon training program. Products are sold to healthcare institutions and surgeons in 35+ countries.
Is Keri Medical a public or private company?
Keri Medical is a private company. It is classified as corporate owned and is currently operating.
When was Keri Medical founded?
Keri Medical was founded in 2016. It employs 101 to 250 people.
Where is Keri Medical based?
Keri Medical is headquartered in Geneva, Switzerland, in the Europe region.
How does Keri Medical make money?
One revenue line is on record: medical Device Sales.
Who are Keri Medical's main competitors?
Broad incumbents on record are Medartis, Integra LifeSciences, Stryker, Zimmer Biomet, Johnson & Johnson MedTech (DePuy Synthes) and Smith+Nephew. Direct peers are Acumed, Skeletal Dynamics, TriMed and Extremity Medical.
Does Keri Medical have an API?
No public API is recorded for Keri Medical.
What industry is Keri Medical in?
Keri Medical's product category is Orthopedic Medical Devices (Hand and Wrist Surgery Implants). Its primary akta.pro industry code is HLAKALAF, Hand & Upper Extremity, with a secondary code of HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS). Its NAICS code is 339112 and its SIC code is 3842.